Candela Announces Health Canada Approval of New Gynecological Indications for CO2RE Laser Platform

Candela Corporation, a leading global aesthetic device company, has announced that Health Canada has approved the CO₂RE laser, the world’s first fully integrated CO₂ workstation, for the treatment of genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) in adult women.
The CO2RE laser, a single CO₂ platform equipped with six treatment modes and multiple customized handpieces, is indicated for use in 10 medical specialties, including dermatology, aesthetics and gynecology. The CO₂RE laser with Intima handpiece and module provides practitioners a simple and efficient gynecological solution for the treatment of the introitus, vaginal canal and external genitalia.